DELFI Diagnostics

Delfi Diagnostics

Biotechnology, 2809 Boston St Ste 503, Baltimore, Maryland, 21224, United States, 51-200 Employees

delfidiagnostics.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 18*********

Who is DELFI DIAGNOSTICS

DELFI uses artificial intelligence and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.

Read More

map
  • 2809 Boston St Ste 503, Baltimore, Maryland, 21224, United States Headquarters: 2809 Boston St Ste 503, Baltimore, Maryland, 21224, United States
  • 2019 Date Founded: 2019
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8071 | NAICS Code: 621511 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from DELFI DIAGNOSTICS

DELFI Diagnostics Org Chart and Mapping

Employees

Jeff Nawrocki

Staff Clinical Data Scientist

Alissa Konicki

Research Data Coordinator

Benjamin Wilson

Associate Director, Clinical Statistical Sciences

Jeffery Campusano

Clinical Laboratory Associate

Jeff Calhoun

Staff Systems Engineer

Ariel Gershman

Senior Bioinformatics Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding DELFI Diagnostics

Answer: DELFI Diagnostics's headquarters are located at 2809 Boston St Ste 503, Baltimore, Maryland, 21224, United States

Answer: DELFI Diagnostics's phone number is 18*********

Answer: DELFI Diagnostics's official website is https://delfidiagnostics.com

Answer: DELFI Diagnostics's revenue is $1 Million to $5 Million

Answer: DELFI Diagnostics's SIC: 8071

Answer: DELFI Diagnostics's NAICS: 621511

Answer: DELFI Diagnostics has 51-200 employees

Answer: DELFI Diagnostics is in Biotechnology

Answer: DELFI Diagnostics contact info: Phone number: 18********* Website: https://delfidiagnostics.com

Answer: DELFI uses artificial intelligence and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access